Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Ending Cash Position : ¥184 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Ending Cash Position?

Wanbangde Pharmaceutical Holding Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥184 Mil.

Wanbangde Pharmaceutical Holding Group Co's quarterly Ending Cash Position declined from Sep. 2023 (¥307 Mil) to Dec. 2023 (¥218 Mil) and declined from Dec. 2023 (¥218 Mil) to Mar. 2024 (¥184 Mil).

Wanbangde Pharmaceutical Holding Group Co's annual Ending Cash Position declined from Dec. 2021 (¥907 Mil) to Dec. 2022 (¥439 Mil) and declined from Dec. 2022 (¥439 Mil) to Dec. 2023 (¥218 Mil).

Wanbangde Pharmaceutical Holding Group Co Ending Cash Position Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Ending Cash Position Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

652.89

565.80

907.15

439.05

218.15

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															434.50	291.81	307.05	218.15	183.66

Wanbangde Pharmaceutical Holding Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Wanbangde Pharmaceutical Holding Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	439.046	+	-220.895
	=	218

Wanbangde Pharmaceutical Holding Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	218.151	+	-34.495
	=	184

Wanbangde Pharmaceutical Holding Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008

Website

http://www.wepon.com.cn

Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.

Executives

Zhao Shou Ming	Directors, executives
Wang Tian Fang	Director
Li Rong Fang	Supervisors
Zhu Jian Xin	Directors, executives
Yang Jin Rong	Executives
Song Tie He	Directors, executives
Song Jian Hua	Executives
Pan Yun Chu	Director
Yu Ju Ming	Executives
Yang Mei Gen	Executives
Tao Jian Feng	Supervisors
Qian Shu Sheng	Executives
Shen Bai Ming	Director
Xu Yin Sheng	Director
Shuang Zhi Wei	Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines